BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 34517832)

  • 1. Rosai-Dorfman disease in the central nervous system with two isolated lesions originated from a single clone: a case report.
    Jin H; Yu Z; Tian T; Shen G; Chen W; Fan M; He Q; Xu F; Liu D
    BMC Neurol; 2021 Sep; 21(1):352. PubMed ID: 34517832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRAF mutation leading to central nervous system rosai-dorfman disease.
    Richardson TE; Wachsmann M; Oliver D; Abedin Z; Ye D; Burns DK; Raisanen JM; Greenberg BM; Hatanpaa KJ
    Ann Neurol; 2018 Jul; 84(1):147-152. PubMed ID: 30014527
    [TBL] [Abstract][Full Text] [Related]  

  • 3. How I Diagnose Rosai-Dorfman Disease.
    Ravindran A; Rech KL
    Am J Clin Pathol; 2023 Jul; 160(1):1-10. PubMed ID: 37167084
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recurrent central nervous system Rosai-Dorfman disease with KRAS mutation: a case report.
    Wang Q; Ren H; Zheng L; Wang J; Zhong D
    Diagn Pathol; 2023 Feb; 18(1):21. PubMed ID: 36782249
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rosai-Dorfman Disease Harboring an Activating KRAS K117N Missense Mutation.
    Shanmugam V; Margolskee E; Kluk M; Giorgadze T; Orazi A
    Head Neck Pathol; 2016 Sep; 10(3):394-9. PubMed ID: 26922062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Systemic Rosai-Dorfman disease with central nervous system involvement.
    Tan S; Ruan L; Jin K; Wang F; Mou J; Huang H; Yang G
    Int J Neurosci; 2018 Feb; 128(2):192-197. PubMed ID: 28881164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rosai-Dorfman-Destombes disease - histiocytic disorder with inflammatory manifestation.
    Adam Z; Adamová Z; Pour L; Řehák Z; Koukalová R; Král Z
    Klin Onkol; 2022; 35(4):262-170. PubMed ID: 35989082
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterizing Rosai-Dorfman disease with [
    Zhang J; Cui R; Li J; Cao X; Luo Y
    Eur Radiol; 2023 Sep; 33(9):6492-6501. PubMed ID: 36971850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rosai-Dorfman disease involving the central nervous system: seven cases from one institute.
    Tian Y; Wang J; Li M; Lin S; Wang G; Wu Z; Ge M; Pirotte BJ
    Acta Neurochir (Wien); 2015 Sep; 157(9):1565-71. PubMed ID: 26210482
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare presentation of Rosai-Dorfman-Destombes disease with central nervous system involvement and cutaneous wounds.
    Workman L; Fang L; Ayoub S; Bach K; Simman R
    J Wound Care; 2024 May; 33(Sup5):S10-S13. PubMed ID: 38683815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isolated Rosai-Dorfman disease of the spine: A systematic literature review.
    Slouma M; Bouzid S; Tlili K; Yedaes D; Radhwen K; Gharsallah I
    Clin Neurol Neurosurg; 2024 Apr; 239():108206. PubMed ID: 38461672
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Successful treatment with azathioprine of relapsing Rosai-Dorfman disease of the central nervous system.
    Le Guenno G; Galicier L; Uro-Coste E; Petitcolin V; Rieu V; Ruivard M
    J Neurosurg; 2012 Sep; 117(3):486-9. PubMed ID: 22725985
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cutaneous Rosai-Dorfman disease: clinicopathological profiles, spectrum and evolution of 21 lesions in six patients.
    Wang KH; Chen WY; Liu HN; Huang CC; Lee WR; Hu CH
    Br J Dermatol; 2006 Feb; 154(2):277-86. PubMed ID: 16433797
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Testicular Rosai-Dorfman disease clonally related to CMML - Case report and literature review.
    Fiegl A; Dirnhofer S; Juskevicius D; Zagrapan B; Dertinger S; Bösl A; Milos S; Brunner J; Bertolini F; Offner FA
    Pathol Res Pract; 2023 Jul; 247():154548. PubMed ID: 37216748
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of central nervous system Rosai-Dorfman disease: A single center treatment experience.
    Zhu Q; Liang Y; Fan Z; Liu Y; Zhou C; Zhang H; Li T; Zhou Y; Yang J; Wang L
    J Clin Neurosci; 2022 May; 99():275-281. PubMed ID: 35325725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Cutaneous Rosai-Dorfman disease with lack of BRAF-V600, KRAS or NRAS mutations: A reactive or neoplastic disorder?].
    Machado I; Alcacer Fernández-Coronado J; Requena C; Través V; Latorre Martínez N; Ortega J; Requena L; Alcacer García J
    Rev Esp Patol; 2022; 55(1):52-56. PubMed ID: 34980442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Consensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease.
    Abla O; Jacobsen E; Picarsic J; Krenova Z; Jaffe R; Emile JF; Durham BH; Braier J; Charlotte F; Donadieu J; Cohen-Aubart F; Rodriguez-Galindo C; Allen C; Whitlock JA; Weitzman S; McClain KL; Haroche J; Diamond EL
    Blood; 2018 Jun; 131(26):2877-2890. PubMed ID: 29720485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial Rosai-Dorfman Disease Involving the Cavernous Sinus: A Case Report and Review of the Literature.
    Li Z; Zhou C; Chen G; Bao Y
    World Neurosurg; 2018 Nov; 119():249-255. PubMed ID: 30099183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A lethal intracranial Rosai-Dorfman disease of the brainstem diagnosed at autopsy.
    Imada H; Sakatani T; Sawada M; Matsuura T; Fukushima N; Nakano I
    Pathol Int; 2015 Oct; 65(10):549-53. PubMed ID: 26184902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isolated intracranial Rosai-Dorfman disease mimicking petroclival meningioma in a child: Case report and review of the literature.
    Yang X; Liu J; Ren Y; Richard SA; Zhang Y
    Medicine (Baltimore); 2017 Nov; 96(47):e8754. PubMed ID: 29381971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.